Black Rock Inc. Bright Minds Biosciences Inc. Transaction History

Black Rock Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 12, 2022	BUY	$1.44 - $3.37 $8,110 - $18,979	5,632 Added 91.3%	11,801 $18,000
Q4 2021 Feb 10, 2022	BUY	$3.17 - $8.23 $19,555 - $50,770	6,169 New	6,169 $20,000

Ticker DRUG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,209,900
Market Cap $640M
Description
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collabor...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.